Ursodeoxycholic acid (UDCA) 500 mg

DRUG3 trials

Sponsors

Tanta University, First Affiliated Hospital Xi'an Jiaotong University

Conditions

Glucose IntoleranceHyperlipidemiaRheumatoid ArthritisStatin TherapyUrsodeoxycholic Acid

Phase 2

Evaluating the Effect of Digoxin and Ursodeoxycholic Acid in Patients With Rheumatoid Arthritis

CompletedNCT04834557

Tanta UniversityRheumatoid Arthritis

Start: 2021-11-01End: 2022-09-30Updated: 2023-03-22

Evaluating the Effect of Ursodeoxycholic Acid in Patients With Rheumatoid Arthritis

CompletedNCT05973370

Tanta UniversityRheumatoid Arthritis

Start: 2023-05-01End: 2024-05-30Updated: 2024-06-03

Unknown Phase

Ursodeoxycholic Acid Attenuates Statin-Induced Impaired Glucose Tolerance

RecruitingNCT06684106

First Affiliated Hospital Xi'an Jiaotong UniversityGlucose Intolerance, Hyperlipidemia, Statin Therapy +1

Start: 2024-11-25End: 2027-06-01Target: 128Updated: 2025-09-19

Related Papers

Efficacy of the cardiac glycoside digoxin as an adjunct to csDMARDs in rheumatoid arthritis patients: a randomized, double-blind, placebo-controlled trial

Frontiers in Pharmacology2024-10-212 citations